Patient-reported short-term and long-term physical and psychologic symptoms: Results of the continuous hyperfractionated accelerated radiotherapy (CHART) randomized trial in non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 16, Issue 9, 1998, Pages 3082-3093

  Bailey, Andrea J ^a   Parmar, Mahesh K B ^a   Stephens, Richard J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; AREA UNDER THE CURVE; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH CARE COST; HEARTBURN; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; SYMPTOM; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0031692883     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.9.3082     Document Type: Article

References (25)

1. Wilson GD, McNally NJ, Dische S, Saunders MI, et al: Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 58:423-431, 1988
2. Fowler JF: The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679-694, 1989
3. Saunders MI, Dische S: Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 19:1211-1215, 1990
4. Saunders M, Dische S, Barrett A, et al: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: A randomised multicentre trial. Lancet 350:161-165, 1997
5. Dische S, Saunders M, Barrett A, et al: A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44:123-136, 1997
6. De Haes JCJM, Knippenberg FCE, Neijt JP: Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034-1038, 1990
7. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361-370, 1983
8. Cox DR, Fitzpatrick R, Fletcher AE, et al: Quality-of-Life assessment: we keep it simple? (with discussion) J R Stat Soc A 155:353-393, 1992
9. COMPACT Steering Committee: Improving the quality of clinical trials in cancer. Br J Cancer 63:412-415, 1991
10. Matthews JNS, Altman DG, Campbell MJ, et al: Analysis of serial measurements in medical research. Br Med J 300:230-235, 1990
11. Medical Research Council Lung Cancer Working Party: Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 63:265-270, 1991
12. Medical Research Council Lung Cancer Working Party: A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 65:934-941, 1992
13. SAS. Cary, NC, SAS Institute Inc, 1989
14. Hollen PJ, Gralla RJ, Cox C, Eberly SW, et al: A dilemma in analysis: Issues in the serial measurement of quality of life in patients with advanced lung cancer. Lung Cancer 18:199-136, 1997
15. Altman DG: Practical Statistics for Medical Research. London, United Kingdom, Chapman & Hall, 1991
16. Hopwood P, Stephens RJ: Symptoms at presentation for treatment in patients with lung cancer: Implications for the evaluation of palliative treatment. Br J Cancer 71:633-636, 1995
17. Murphy JM, Olivier DC, Monson RR, et al: Incidence of depression and anxiety: The Stirling County study. Am J Public Health 78:534-540, 1988
18. Coyle D, Drummond MF: Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Clin Oncol 9:313-321, 1997
19. Stephens RJ, Hopwood P, Girling DJ, et al: Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res 6:225-236, 1997
20. Sprangers MAG, Aaronson NK: The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. J Clin Epidimiol 45:743-760, 1992
21. Sneeuw KCA, Aaronson NK, Sprangers MAG, et al: Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol 15:1206-1217, 1997
22. Dales RE, Belanger R, Shamji FM, et al: Quality of life following thoractomy for lung cancer. J Clin Epidimiol 47:1443-1449, 1994
23. Hopwood P, Stephens RJ, Machin D: Approaches to the analysis of quality of life data: Experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 3:339-352, 1994
24. Fayers PM, Hopwood P, Harvey A, et al: Quality of life assessment in clinical trials - Guidelines and a checklist for protocol writers: The UK Medical Research Council experience. Eur J Cancer 33:20-28, 1997
25. Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144, 1998